By Dr. Eric Grigsby Dr. Eric Grigsby, CEO and Found of Neurovations Diabetic peripheral neuropathy is a debilitating, progressive neurologic disorder that affects about 30% of adults with diabetes. Spinal […]
NIH HEAL Initiative: Coordinating Center for National Pain Scientists Career Development Grant awarded to Neurovations Education Division CEO and Founder of Neurovations, Dr. Eric Grigsby NAPA, Calif., Oct. 13, 2022 /PRNewswire/ — […]
NAPA, Calif., Sept. 28, 2022 /PRNewswire/ — Neurovations now offers transcranial magnetic stimulation (TMS) for the treatment of Major Depressive Disorder (MDD) — making it the first mental health provider of TMS Therapy in Napa […]
Dr. Katalin Karikó, co-inventor of the modified mRNA technology used in vaccines to prevent COVID-19 infection, keynotes the Napa Pain Conference August 23. 2022 Napa, CALIF, – Approximately 600 top […]
NeuroTech Reports by James Cavuoto, editor and publisher Several hundred pain clinicians attended the 28th Napa Pain Conference in Napa, CA earlier this month. The event, produced by Neurovations Education, […]
This inaugural podcast focuses on Neurovations, Napa Pain Institute and N3 Laboratories. CEO and Founder Dr. Eric Grigsby focuses on what chronic pain really means. Eric Grigsby, nationally-renowned pain care […]
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.